Company profile: QLT
1.1 - Company Overview
Company description
- Provider of innovative ocular products, specializing in biotechnology and dedicated to their development and commercialization.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to QLT
Altar
HQ: France
Website
- Description: Provider of biotechnology solutions in automated fluidics, developing and operating proprietary technologies that bring microbes to performance suitable for commercial use. Serves customers leveraging microorganisms to produce food, feed, flavors & fragrances, cosmetics, and fuels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altar company profile →
BAC
HQ: United States
Website
- Description: Provider of affinity purification products and services for the biopharmaceutical market, with CaptureSelect products used from drug discovery to manufacturing of biopharmaceuticals, based on a proprietary platform integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BAC company profile →
Cytoo
HQ: France
Website
- Description: Provider of life science research products and cell-based assay solutions that make cellular analysis robust and reliable by decreasing cell variability, including high content screening (96-well, 384 format coming), micropatterning technology, OncoSpheres 3D spheroids, Arena and custom chips, and standard, starter, and motility plates for high-throughput, multiplexed analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytoo company profile →
Isobionics
HQ: The Netherlands
Website
- Description: Provider of isoprenoid-based flavor and fragrance ingredients produced via a proprietary biotechnology process for the food, beverage, flavor and fragrance markets, delivering higher quality and purity at lower production cost. Portfolio includes Natural Nootkatone, beta-Caryophyllene, Valencene, (-)-alpha-Bisabolol, alpha-Bisabolene, and beta-Bisabolene.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Isobionics company profile →
ModiQuest Research
HQ: The Netherlands
Website
- Description: Provider of custom antibody generation and development services, specializing in monoclonal antibodies against difficult target antigens for R&D, diagnostic and therapeutic applications, using proprietary ModiFuse (hybridoma electrofusion), ModiSelect (B-cell selection) and ModiPhage (phage display) technologies to generate very large panels of monoclonal antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ModiQuest Research company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for QLT
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to QLT
2.2 - Growth funds investing in similar companies to QLT
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for QLT
4.2 - Public trading comparable groups for QLT
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →